Showing results (1861-1870 of 2,020) with videos related to

Sort By:
Pageof 202
Development (Cambridge, England)|December 13, 2019
Neural crest cells bulldoze through the microenvironment using Aquaporin 1 to stabilize filopodiaRebecca McLennan, Mary C McKinney, Jessica M Teddy, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 22, 2016
Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination PerformanceFrances A Collichio, Brian J Hess, Elaine A Muchmore, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|December 2, 2014
Targeted deletion of Tsc1 causes fatal cardiomyocyte hyperplasia independently of afterloadUsamah S Kayyali, Christopher G Larsen, Sarah Bashiruddin, et al.
Developmental Biology|August 18, 2015
VEGF signals induce trailblazer cell identity that drives neural crest migrationRebecca McLennan, Linus J Schumacher, Jason A Morrison, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex VirusesPeter J Ireland, John E Tavis, Michael P D'Erasmo, et al.
Development (Cambridge, England)|May 16, 2015
Neural crest migration is driven by a few trailblazer cells with a unique molecular signature narrowly confined to the invasive frontRebecca McLennan, Linus J Schumacher, Jason A Morrison, et al.
Plos Genetics|January 20, 2010
A comprehensive map of insulator elements for the Drosophila genomeNicolas Nègre, Christopher D Brown, Parantu K Shah, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 11, 2017
An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodesFrederick A Partridge, Anwen E Brown, Steven D Buckingham, et al.
JCO Oncology Practice|September 20, 2022
Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic CancerRachel B Jimenez, Caroline Schenkel, Laura A Levit, et al.
Pageof 202